▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Keith Speights

TMFFishBiz

Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

Recent Articles by Keith Speights

Warren Buffett frowning TMF photo

Dec 18, 2022 by Keith Speights

Is a New Bull Market Imminent? Warren Buffett Doesn't Seem to Think So

Warren Buffett's actions (and lack thereof) speak volumes about his mindset.

Woman with fingers crossed laptop

Dec 17, 2022 by Keith Speights, David Jagielski, and Prosper Junior Bakiny

3 Beaten-Down Stocks That Could Explode Higher in 2023

These stocks could have significant upside opportunities ahead.

DNA with icons and doctor

Dec 17, 2022 by Keith Speights and Adria Cimino

Invitae Stock: Bull vs. Bear

The bears have prevailed with Invitae this year. But could the future be better for the beaten-down stock?

Buffett12 TMF

Dec 17, 2022 by Keith Speights

Warren Buffett and Elon Musk Agree: Follow This Investing Advice

When two very different multibillionaires have the same advice, it's worth paying attention.

Worried couple, laptop

Dec 17, 2022 by Keith Speights

Should You Buy Stocks If a Recession Is Coming in 2023? Here's What History Shows.

Stocks usually go down during recessions, but long-term investors can still come out on top.

Person with arms folded, laptop

Dec 17, 2022 by Keith Speights

Want the Max $4,555 Social Security Benefit? Here's the Salary You Need

It's actually not just one amount that you'll need to make to receive the max Social Security retirement benefit.

2 healthcare professionals and patient getting vaccine

Dec 16, 2022 by Keith Speights

Why Pfizer Stock Is Riskier Than AbbVie

Pfizer has a lot more revenue at risk over the next several years than AbbVie does.

Scientist, monitors with DNA

Dec 14, 2022 by Keith Speights

Is Moderna Stock a Buy After Its Impressive Cancer Vaccine Results?

Moderna could have a winner with its personalized cancer vaccine. But the company also faces big questions.

Buffett6 TMF

Dec 14, 2022 by Keith Speights

If Warren Buffett Could Tell You 1 Investment to Make, This Would Probably Be It

Buffett definitely thinks this investment is a good bet.

Hands behind head

Dec 14, 2022 by Keith Speights

Here Are the Best Ultra-High-Yield Dividend Stocks to Buy Right Now

Not all ultra-high-yield dividends are too good to be true.

COVID - scientist, vaccine

Dec 13, 2022 by Keith Speights

Why Moderna Stock Is Skyrocketing Today

Moderna's personalized cancer vaccine program just received a big boost.

Hands behind head, young woman

Dec 13, 2022 by Keith Speights

3 High-Flying Stocks to Buy and Hold If a Recession Is on the Way

An economic downturn shouldn't hurt these stocks.

Person holding laptop in data center

Dec 13, 2022 by Keith Speights

Could This Multibillion-Dollar Bonanza Boost Amazon Stock?

Amazon was one of four winners of a major federal government cloud contract.

Oil rig workers talking

Dec 13, 2022 by Keith Speights

3 Stocks That Could Double Your Money in 10 Years on Dividends Alone

You could make even more money if these stocks perform well -- which is quite possible.

Big fish eating little fish

Dec 12, 2022 by Keith Speights

Why Horizon Therapeutics Stock Is Soaring Today

Amgen's planned acquisition of Horizon could close in the first half of next year.

Two people with iPad and laptop

Dec 12, 2022 by Keith Speights

3 Top Stocks to Buy Hand Over Fist Before the End of 2022

You probably shouldn't wait for long to buy these stocks.

Getty - couple high-five happy

Dec 12, 2022 by Keith Speights

Try These 3 No-Brainers to Beat the Average $1,677 Social Security Benefit

You don't have to be average.

Warren Buffett - TMF

Dec 11, 2022 by Keith Speights

3 Warren Buffett Dividend Stocks That Generate Monster Passive Income

These Berkshire Hathaway portfolio holdings will pay income investors handsomely.

Chart, Asian woman pointing

Dec 11, 2022 by Keith Speights

3 Red-Hot Stocks That Could Continue to Beat the Market

The success these stocks achieved in 2022 could be just the beginning.

Scientists in a lab, smiling

Dec 10, 2022 by Keith Speights, David Jagielski, and Prosper Junior Bakiny

3 High-Flying Stocks in 2022 That Should Keep Soaring in 2023

These stocks' tailwinds should continue blowing in the new year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services